• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar

McCarter & English Logo

  • People
  • Services
  • Insights
  • Our Firm
    • Leadership Team
    • Social Justice
    • Diversity, Equity & Inclusion
    • Pro Bono
    • Client Service Values
    • Alumni
  • Join Us
    • Lawyers
    • Summer Associates
    • Patent Professionals
    • Professional Staff
    • Job Openings
  • Locations
    • Boston
    • Philadelphia
    • East Brunswick
    • Indianapolis
    • Stamford
    • Hartford
    • Trenton
    • Miami
    • Washington, DC
    • New York
    • Wilmington
    • Newark
  • Share

Share

Browse Alphabetically:

  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z
  • All
Bankruptcy, Restructuring & Litigation
Blockchain, Smart Contracts & Digital Currencies
Business Litigation
Cannabis
Coronavirus Resource Center
Corporate
Crisis Management
Cybersecurity & Data Privacy
Delaware Corporate, LLC & Partnership Law
Design, Fashion & Luxury
E-Discovery & Records Management
Energy & Utilities
Environment & Energy
Financial Institutions
Food & Beverage
Government Affairs
Government Contracts & Global Trade
Government Investigations & White Collar Defense
Healthcare
Hospitality
Immigration
Impact Investing
Insurance Recovery, Litigation & Counseling
Intellectual Property
Labor & Employment
Life Sciences
Manufacturing
Products Liability, Mass Torts & Consumer Class Actions
Public Finance
Real Estate
Renewable Energy
Sports & Entertainment
Tax & Employee Benefits
Technology Transactions
Transportation, Logistics & Supply Chain Management
Trusts, Estates & Private Clients
Venture Capital & Emerging Growth Companies
  • Broadcasts
  • Events
  • News
  • Publications
  • View All Insights
Search By:
Peter Campitiello
Alternate image for Peter Campitiello

Peter Campitiello

Partner

East Brunswick Office Managing Partner

732.867.9741
East Brunswick
New York
pcampitiello@mccarter.com

Peter Campitiello, East Brunswick Office Managing Partner, represents public and private companies in corporate, securities, and commercial matters, including financing, mergers and acquisitions, corporate governance, and regulatory issues. He provides proactive and business-focused solutions, leveraging his broad network of funding, marketing and support firms for the benefit of his clients.

Peter routinely serves as outside general counsel to companies in the life sciences, alternative energy, cannabis, and private equity industries at all stages of their business life-cycle, advising on the many complex legal issues affecting their businesses. He has represented numerous companies in going public transactions, from organization through initial offerings, financing, and securities listings.

Representative Matters

Iveda Solutions—PIPE

Closed a $5 million PIPE for our client Iveda Solutions, Inc. (Nasdaq: IVDA)—which specializes in IoT platforms that offer service providers a turn-key cloud video surveillance system, smart sensors, and intelligent video search technology—with institutional investors of common stock, pre-funded warrants and warrants. 

Interactive Offers—Sale

Helped digital advertising platform Interactive Offers, LLC, sell its business to Grove, Inc. (Nasdaq: GRVI) for $6.1 million in cash and stock. 

Signing Day Sports—Financing

Helped digital sports recruiting platform Signing Day Sports, Inc., close on the pre-IPO bridge round for $6.3 million in advance of their IPO on Nasdaq next quarter. 

BioHiTech Global—Common stock purchase agreement

Represented BioHiTech Global, Inc. (Nasdaq: BHTG), a sustainable technology and services company, in a $20 million Common Stock Purchase Agreement with Keystone Capital Partners.

Axelerex—Reverse merger

Handled the reverse merger of Biosecurity Technology, LLC, which provides business solutions designed to reduce the risk of transmission of infectious diseases, into Axelerex Corp. (OTC: AEXL), and the simultaneous private placement of its common stock.  

Chondrial Therapeutics—Signing of definitive merger agreement

Assisted Chondrial Therapeutics, Inc., in entering into a definitive merger agreement with Zafgen, Inc., under which Chondrial will acquire Zafgen in a reverse merger wherein the stockholders of Chondrial will become the majority owners of Zafgen’s outstanding common stock. Stockholders of Chondrial will receive shares of newly issued Zafgen common stock equal to approximately 60% of the company following the merger. 

NanoViricides—Underwritten offering

Represented NanoViricides, Inc. in an underwritten offering of $11.5 million.

BioHiTech Global—Underwritten offering

Represented BioHiTech Global, Inc. in an underwritten offering of $9.5 million.

NanoViricides—Market offering

Represented NanoViricides, Inc. in a market offering of $50 million.

NanoViricides—Public offering

Represented NanoViricides, Inc. in a public offering of $10.2 million.

NanoViricides—Underwritten offering

Represented NanoViricides, Inc. in an underwritten offering of $8.625 million.

BioHiTech Global—Public offering

Represented BioHiTech Global, Inc. in a public offering of $3.15 million.

sidebar

pdfemail

Services

Corporate
Debt Financings
Mergers & Acquisitions
Private Equity
Capital Markets
Cannabis
Venture Capital & Emerging Growth Companies
Life Sciences

Education

New York Law School JD
La Salle University BA, cum laude

Bar Admissions

New York
*not admitted in New Jersey

Memberships & Certifications

American Bar Association

Insights Speaking Microphone
News
Peter Campitiello Interviewed by Unblinded
8.16.2022
Insights Speaking Seminar
Events|Webinar
Venture Summit Virtual Connect Global
youngStartUp Ventures
7.6.21-7.8.21
Media item displaying SEC Modernizes Reporting Requirements for Public Companies Under Regulation S-K Items 101, 103, and 105
Publications|Alert
SEC Modernizes Reporting Requirements for Public Companies Under Regulation S-K Items 101, 103, and 105
Corporate Compliance Insights / Corporate Alert
12.10.2020
Insights Broadcast Microphone
Events|Webinar
Corporate Venture Funding: What You Need to Know
youngStartUp Ventures: Venture Summit Virtual Connect Global
8.6.2020
Media item displaying Mary Gabriel, Natalie Mantell, and Venture Capital & Emerging Growth Practice Recognized by New Jersey Law Journal
News|Recognition
Mary Gabriel, Natalie Mantell, and Venture Capital & Emerging Growth Practice Recognized by New Jersey Law Journal
New Jersey Law Journal
6.9.2020
Insights Broadcast Microphone
Events|Webinar
Raising Strategic/ Corporate Venture Funding: What You Need to Know
youngStartUp Ventures: Venture Summit West 2020
5.7.2020
Insights News Headline Stack
News|Press
Chondrial Therapeutics and Zafgen Announce Definitive Merger Agreement
12.18.2019
McCarter & English, LLP
Copyright © 2023 McCarter & English, LLP. All Rights Reserved.
  • Login
  • Attorney Advertising
  • Privacy
  • Awards Methodology
  • Contact
  • Subscribe
  • Sitemap

The McCarter & English, LLP website is for informational purposes only. We do not provide legal advice on this website. We can provide legal advice only to our clients in specific inquiries that they address to us. If you are interested in becoming a client, please contact us, but do not send any information about your specific legal question. We cannot serve as your lawyers until we establish an attorney-client relationship, which can occur only after we follow procedures within our firm and after we agree to the terms of the representation.

Accept Cancel